prenetics global ltd - PRE

PRE

Close Chg Chg %
15.83 -0.11 -0.69%

Closed Market

15.72

-0.11 (0.69%)

Volume: 145.86K

Last Updated:

Jan 14, 2026, 4:00 PM EDT

Company Overview: prenetics global ltd - PRE

PRE Key Data

Open

$15.80

Day Range

15.50 - 16.21

52 Week Range

3.09 - 18.48

Market Cap

$223.29M

Shares Outstanding

14.11M

Public Float

9.90M

Beta

0.34

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$3.65

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

155.27K

 

PRE Performance

1 Week
 
1.22%
 
1 Month
 
5.82%
 
3 Months
 
4.80%
 
1 Year
 
177.96%
 
5 Years
 
N/A
 

PRE Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About prenetics global ltd - PRE

Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm offers scientifically formulated supplements under the IM8 brand, sports nutrition products under the Europa platform, and direct-to-consumer DNA tests through the CircleDNA brand. It is also involved in establishing a Bitcoin treasury for the exploration of applications within the healthcare ecosystem. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and has dual headquartered in Charlotte, the United States and Hong Kong.

PRE At a Glance

Prenetics Global Ltd.
K11 Atelier Kings Road
Hong Kong,
Phone 852-2210-9588 Revenue 30.62M
Industry Financial Conglomerates Net Income -46,304,000.00
Sector Finance 2024 Sales Growth 40.834%
Fiscal Year-end 12 / 2025 Employees 285
View SEC Filings

PRE Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.367
Price to Book Ratio 0.437
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.364
Enterprise Value to Sales 0.535
Total Debt to Enterprise Value 0.352

PRE Efficiency

Revenue/Employee 107,442.105
Income Per Employee -162,470.175
Receivables Turnover 5.463
Total Asset Turnover 0.131

PRE Liquidity

Current Ratio 2.26
Quick Ratio 2.08
Cash Ratio 1.719

PRE Profitability

Gross Margin 34.013
Operating Margin -166.19
Pretax Margin -182.63
Net Margin -151.216
Return on Assets -19.808
Return on Equity -24.593
Return on Total Capital -26.298
Return on Invested Capital -24.342

PRE Capital Structure

Total Debt to Total Equity 3.388
Total Debt to Total Capital 3.277
Total Debt to Total Assets 2.703
Long-Term Debt to Equity 1.769
Long-Term Debt to Total Capital 1.711
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Prenetics Global Ltd - PRE

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
- 275.76M 21.74M 30.62M
Sales Growth
- - -92.12% +40.83%
-
Cost of Goods Sold (COGS) incl D&A
- 144.21M 12.91M 20.21M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 7.54M 7.79M 5.93M
Depreciation
- 5.99M 5.88M 4.02M
Amortization of Intangibles
- 1.56M 1.91M 1.91M
COGS Growth
- - -91.05% +56.48%
-
Gross Income
- 131.55M 8.83M 10.42M
Gross Income Growth
- - -93.29% +17.95%
-
Gross Profit Margin
- +47.71% +40.61% +34.01%
2021 2022 2023 2024 5-year trend
SG&A Expense
3.94M 124.88M 61.34M 61.30M
Research & Development
- 15.52M 11.66M 10.55M
Other SG&A
3.94M 109.36M 49.68M 50.76M
SGA Growth
- +3,067.05% -50.88% -0.06%
Other Operating Expense
- - - -
-
Unusual Expense
(631.59K) 185.65M 7.68M 8.82M
EBIT after Unusual Expense
(3.31M) (178.98M) (60.20M) (59.71M)
Non Operating Income/Expense
4.22K (130.03K) 4.51M 3.99M
Non-Operating Interest Income
- 472.19K 3.92M 2.04M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 4.20M 119.66K 203.00K
Interest Expense Growth
- - -97.15% +69.64%
-
Gross Interest Expense
- 4.20M 119.66K 203.00K
Interest Capitalized
- - - -
-
Pretax Income
(3.31M) (183.31M) (55.81M) (55.92M)
Pretax Income Growth
- -5,442.27% +69.55% -0.20%
Pretax Margin
- -66.47% -256.68% -182.63%
Income Tax
- 7.15M (269.36K) (7.87M)
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- 7.43M 46.44K (7.41M)
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- (279.63K) (315.80K) (466.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(3.31M) (190.45M) (56.40M) (49.83M)
Minority Interest Expense
- (54.000000000499995) (2.05M) (3.50M)
Net Income
(3.31M) (190.45M) (54.35M) (46.33M)
Net Income Growth
- -5,658.36% +71.46% +14.76%
Net Margin Growth
- -69.06% -249.95% -151.29%
Extraordinaries & Discontinued Operations
- - (8.38M) 22.00K
-
Discontinued Operations
- - (8.38M) 22.00K
-
Net Income After Extraordinaries
(3.31M) (190.45M) (62.72M) (46.30M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(3.31M) (190.45M) (62.72M) (46.30M)
EPS (Basic)
-0.8757 -37.5699 -5.5774 -3.7059
EPS (Basic) Growth
- -4,190.27% +85.15% +33.56%
Basic Shares Outstanding
3.78M 5.07M 11.25M 12.49M
EPS (Diluted)
-0.8757 -37.5699 -5.5774 -3.7059
EPS (Diluted) Growth
- -4,190.27% +85.15% +33.56%
Diluted Shares Outstanding
3.78M 5.07M 11.25M 12.49M
EBITDA
(3.94M) 14.21M (44.72M) (44.96M)
EBITDA Growth
- +460.46% -414.62% -0.54%
EBITDA Margin
- +5.15% -205.67% -146.83%

Snapshot

Average Recommendation BUY Average Target Price 32.00
Number of Ratings 1 Current Quarters Estimate 0.24
FY Report Date 03 / 2026 Current Year's Estimate 1.52
Last Quarter’s Earnings 0.04 Median PE on CY Estimate N/A
Year Ago Earnings -2.22 Next Fiscal Year Estimate 5.43
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate 0.24 0.36 1.52 5.43
High Estimates 0.24 0.36 1.52 5.43
Low Estimate 0.24 0.36 1.52 5.43
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Prenetics Global Ltd in the News